Bone Morphogenetic Protein Receptor Type-2 (BMPR2) Antibody

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.
Description
Bone Morphogenetic Protein Receptor Type-2 (BMPR2) Antibody is a Rabbit polyclonal antibody for the detection of Human Bone Morphogenetic Protein Receptor Type-2 (BMPR2).
Documents del producto
Product specifications
| Category | Primary Antibodies |
| Immunogen Target | Bone Morphogenetic Protein Receptor Type-2 (BMPR2) |
| Host | Rabbit |
| Reactivity | Human |
| Recommended Dilution | Optimal dilutions/concentrations should be determined by the end user. |
| Clonality | Polyclonal |
| Conjugation | Unconjugated |
| Isotype | IgG |
| Size 1 | 50 µg |
| Size 2 | 100 µg |
| Form | Liquid |
| Tested Applications | ELISA, WB, IHC |
| Buffer | 0.01 M PBS, pH 7.4, 50% glycerol, 0.05% Proclin-300. |
| Availability | Shipped within 5-12 working days. |
| Storage | Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles. |
| Dry Ice | No |
| UniProt ID | Q13873 |
| Gene ID | 659 |
| NCBI Accession | NP_001195.2 |
| Background | Antibody anti-BMPR2 |
| Status | RUO |
Descripción
Related Products

Human BMPR2 (Bone morphogenetic protein receptor type-2) ELISA Kit
Ver Producto
BMPR2 antibody
On ligand binding, forms a receptor complex consisting of two type II and two type I transmembrane serine/threonine kinases. Type II receptors phosphorylate and activate type I receptors which autophosphorylate, then bind and activate SMAD transcriptional regulators. Binds to BMP7, BMP2 and, less efficiently, BMP4. Binding is weak but enhanced by the presence of type I receptors for BMPs. Mediates induction of adipogenesis by GDF6.
Ver Producto
BMPR2 antibody
On ligand binding, forms a receptor complex consisting of two type II and two type I transmembrane serine/threonine kinases. Type II receptors phosphorylate and activate type I receptors which autophosphorylate, then bind and activate SMAD transcriptional regulators. Binds to BMP7, BMP2 and, less efficiently, BMP4. Binding is weak but enhanced by the presence of type I receptors for BMPs. Mediates induction of adipogenesis by GDF6.
Ver Producto